Spectrum of CNS disease caused by rapidly growing mycobacteria

The Lancet Infectious Diseases

Volumn 8, Issue 6, 2008, Pages 390-398

  Talati, Naasha J ^a   Rouphael, Nadine ^a   Kuppalli, Krutika ^a   Franco Paredes, Carlos ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Children's Hospital of Mexico Federico Gomez   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMMUNOMODULATING AGENT; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PREDNISONE; STEROID; SULFAMETHOXAZOLE; TIGECYCLINE;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BLOOD BRAIN BARRIER; CASE REPORT; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DRUG DOSE REDUCTION; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; NEUROIMAGING; NEUROSURGERY; PLEOCYTOSIS; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; TUBERCULOUS MENINGITIS;

ADULT; ANTITUBERCULAR AGENTS; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; FEMALE; HUMANS; MENINGOENCEPHALITIS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

EID: 43849098579     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(08)70127-0     Document Type: Review

References (65)

1. Flor A., Capdevila J., Martin N., Gavalda J., and Pahissa A. Nontuberculous mycobacterial meningitis: report of two cases and review. Clin Infect Dis 23 (1996) 1266-1273
2. Carson L., Bland L., Cusick L., et al. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 54 (1988) 3122-3125
3. O'Brien R., Geiter L., and Snider D. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 135 (1987) 1007-1014
4. Brown-Elliott B., and Wallace R. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15 (2002) 716-746
5. Wallace R. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 13 (1994) 953-960
6. Springer B., Bottger E., Kirschner P., and Wallace R. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp nov. Int J Syst Bacteriol 45 (1995) 262-267
7. Wallace R., Swenson J., Silcox V., Good R., Tschen J., and Stone M. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5 (1983) 657-679
8. Galil K., Miller L., Yakrus M., et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis 5 (1999) 681-687
9. Winthrop K., Abrams M., Yakrus M., et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 346 (2002) 1366-1371
10. Wallace R., Brown B., and Onyi G. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166 (1992) 405-412
11. Brady M., Marcon M., and Maddux H. Broviac catheter-related infection due to Mycobacterium fortuitum in a patient with acquired immunodeficiency syndrome. Pediatr Infect Dis J 6 (1987) 492-494
12. Vera G., and Lew S. Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis. Am J Nephrol 19 (1999) 586-589
13. Merlin T., and Tzamaloukas A. Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Clin Pathol 91 (1989) 717-720
14. Clegg H., Foster M., Sanders W., and Baine W. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 147 (1983) 427-433
15. Safranek T., Jarvis W., Carson L., et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 317 (1987) 197-201
16. Wallace R., Musser J., Hull S., et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 159 (1989) 708-716
17. Daley C., and Griffith D. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 23 (2002) 623-632
18. American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156 (1997) S1-S25
19. Griffith D., Girard W., and Wallace R. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147 (1993) 1271-1278
20. Mueller P., and Edson R. Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review. Diagn Microbiol Infect Dis 39 (2001) 33-37
21. Ingram C., Tanner D., Durack D., Kernodle G., and Corey G. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 16 (1993) 463-471
22. Olalla J., Pombo M., Aguado J., et al. Mycobacterium fortuitum complex endocarditis-case report and literature review. Clin Microbiol Infect 8 (2002) 125-129
23. Laskowski L., Marr J., Spernoga J., et al. Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N Engl J Med 297 (1977) 101-102
24. Matieli L., De Freitas D., Sampaio J., Moraes N., Yu M., and Hofling-Lima A. Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature. Retina 26 (2006) 826-829
25. Khooshabeh R., Grange J., Yates M., McCartney A., and Casey T. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis 75 (1994) 377-382
26. John T., and Velotta E. Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications. Cornea 24 (2005) 245-255
27. Chung S., Roh M., Park M., Kong Y., Lee H., and Kim E. Mycobacterium abscessus keratitis after LASIK with IntraLase femtosecond laser. Ophthalmologica 220 (2006) 277-280
28. Ding L., Lai C., Lee L., Huang L., and Hsueh P. Lymphadenitis caused by non-tuberculous mycobacteria in a university hospital in Taiwan: predominance of rapidly growing mycobacteria and high recurrence rate. J Formos Med Assoc 104 (2005) 897-904
29. Butt A. Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. Am J Med Sci 315 (1998) 50-55
30. Franklin D., Starke J., Brady M., Brown B., and Wallace R. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?. Am J Otol 15 (1994) 313-320
31. Lakshmi V., Rao R., and Dinakar I. Bacteriology of brain abscess-observations on 50 cases. J Med Microbiol 38 (1993) 187-190
32. Wallace R., Silcox V., Tsukamura M., et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol 31 (1993) 3231-3239
33. Jacob C., Henein S., Heurich A., and Kamholz S. Nontuberculous mycobacterial infection of the central nervous system in patients with AIDS. South Med J 86 (1993) 638-640
34. Hand W., and Sanford J. Mycobacterium fortuitum-a human pathogen. Ann Intern Med 73 (1970) 971-977
35. Dalovisio J., and Pankey G. Problems in diagnosis and therapy of Mycobacterium fortuitum infections. Am Rev Respir Dis 117 (1978) 625-630
36. Dalovisio J., Pankey G., Wallace R., and Jones D. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 3 (1981) 1068-1074
37. Santamaria-Jauregui J., Sanz-Hospital J., Berenguer J., Munoz D., Gomez-Mampaso E., and Bouza E. Meningitis caused by Mycobacterium fortuitum. Am Rev Respir Dis 130 (1984) 136-137
38. Chan K., Mann K., and Seto W. Infection of a shunt by Mycobacterium fortuitum: case report. Neurosurgery 29 (1991) 472-474
39. Smith M., Boyars M., and Woods G. Fatal Mycobacterium fortuitum meningitis in a patient with AIDS. Clin Infect Dis 23 (1996) 1327-1328
40. Midani S., and Rathore M. Mycobacterium fortuitum infection of ventriculoperitoneal shunt. South Med J 92 (1999) 705-707
41. Madaras-Kelly K., DeMasters T., and Stevens D. Mycobacterium fortuitum meningitis associated with an epidural catheter: case report and a review of the literature. Pharmacotherapy 19 (1999) 661-666
42. Kuruvila M., Mathews P., Jesudason M., and Ganesh A. Mycobacterium fortuitum endocarditis and meningitis after balloon mitral valvotomy. J Assoc Physicians India 47 (1999) 1022-1023
43. Maniu C., Hellinger W., Chu S., Palmer R., and Alvarez-Elcoro S. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clin Infect Dis 33 (2001) 745-748
44. Liebeskind D., Ostrzega N., Wasterlain C., and Buttner E. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology 56 (2001) 810-813
45. Marie I., Heron F., Lecomte F., et al. Multiple cerebral abscesses as a complication of Mycobacterium fortuitum infection. Eur J Intern Med 14 (2003) 386-389
46. Adekambi T., Foucault C., La Scola B., and Drancourt M. Report of two fatal cases of Mycobacterium mucogenicum central nervous system infection in immunocompetent patients. J Clin Microbiol 44 (2006) 837-840
47. Fujikawa K., Suenaga A., Motomura M., Fukuda T., Ooe N., and Eguchi K. A case of Mycobacterium fortuitum meningitis following surgery for meningioma. Rinsho Shinkeigaku 46 (2006) 480-484 (in Japanese).
48. Woods G., Bergmann J., Witebsky F., et al. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 37 (1999) 1676-1682
49. Wallace R., Bedsole G., Sumter G., et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 34 (1990) 65-70
50. Briedis D., and Robson H. Cerebrospinal fluid penetration of amikacin. Antimicrob Agents Chemother 13 (1978) 1042-1043
51. Fraschini F., Scaglione F., and Demartini G. Clarithromycin clinical pharmacokinetics. Clin Pharmacokinet 25 (1993) 189-204
52. MacGowan A. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother 51 suppl 2 (2003) ii17-ii25
53. Rodvold K., Gotfried M., Cwik M., Korth-Bradley J., Dukart G., and Ellis-Grosse E. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 58 (2006) 1221-1229
54. Schmidt T., Froula J., and Tauber M. Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. J Antimicrob Chemother 32 (1993) 627-632
55. Hall-Stoodley L., and Lappin-Scott H. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol Lett 168 (1998) 77-84
56. de Gans J., and van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 347 (2002) 1549-1556
57. Thwaites G., Nguyen D., Nguyen H., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 (2004) 1741-1751
58. Wallace R., Brown-Elliott B., Ward S., Crist C., Mann L., and Wilson R. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 45 (2001) 764-767
59. Spellberg B., Yoo T., and Bayer A. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 54 (2004) 832-835
60. Breedt J., Teras J., Gardovskis J., et al. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother 49 (2005) 4658-4666
61. Oliva ME, Rekha A, Yellin, A et al. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [study ID numbers: 3074A1-301-WW; ClinicalTrials.gov identifier: NCT00081744] BMC Infect Dis 2005: 5 88.
62. Wallace R., Brown-Elliott B., Crist C., Mann L., and Wilson R. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 46 (2002) 3164-3167
63. Hwang J., Koh W., Kim E., et al. Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease. Tuberculosis (Edinb) 86 (2006) 382-385
64. Condos R., Hull F., Schluger N., Rom W., and Smaldone G. Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis. Chest 125 (2004) 2146-2155
65. Colsky A., Hanly A., Elgart G., and Kerdel F. Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy. Arch Dermatol 135 (1999) 125-127